The Value of Combined Detection of Serum PIVKA-II,AFP and HBV-DNA in the Diagnosis and Prognosis Prediction of HBV-induced Liver Cancer

The Value of Combined Detection of Serum PIVKA-II,AFP and HBV-DNA in the Diagnosis and Prognosis Prediction of HBV-induced Liver Cancer

WAN Qiang, ZHAO Bo, WANG Yaoyao

PDF(1134 KB)

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

PDF(1134 KB)

Labeled Immunoassays and Clinical Medicine ›› 2024, Vol. 31 ›› Issue (4) : 685-691. DOI: 10.11748/bjmy.issn.1006-1703.2024.04.019

Clinical Investigation

The Value of Combined Detection of Serum PIVKA-II,AFP and HBV-DNA in the Diagnosis and Prognosis Prediction of HBV-induced Liver Cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 31(4): 685-691 https://doi.org/10.11748/bjmy.issn.1006-1703.2024.04.019

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1134 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉